Thu, March 9, 2023
Wed, March 8, 2023
Tue, March 7, 2023
Mon, March 6, 2023
Fri, March 3, 2023

Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $36 on, Mar 7th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-36-on-mar-7th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $41 to $36 on, Mar 7th, 2023.

Anupam has made no other calls on SNDX in the last 4 months.



There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Anupam


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $32 on, Thursday, March 2nd, 2023
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $33 on, Wednesday, March 1st, 2023
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $34 on, Wednesday, March 1st, 2023
  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023

Publication Contributing Sources